Switch to:

Alexion Pharmaceuticals Total Stockholders Equity

: USD10,491 Mil (As of Jun. 2020)
View and export this data going back to 1996. Start your Free Trial

Alexion Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Jun. 2020 was USD10,491 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Alexion Pharmaceuticals's Book Value per Share for the quarter that ended in Jun. 2020 was USD47.88. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Alexion Pharmaceuticals's Debt-to-Equity for the quarter that ended in Jun. 2020 was 0.25.


Alexion Pharmaceuticals Total Stockholders Equity Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Alexion Pharmaceuticals Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Total Stockholders Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,259.00 8,693.80 8,893.10 9,165.30 11,271.80

Alexion Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Total Stockholders Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,163.50 10,367.20 11,271.80 11,747.80 10,490.80

Alexion Pharmaceuticals  (NAS:ALXN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Alexion Pharmaceuticals's Book Value per Share for the quarter that ended in Jun. 2020 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Alexion Pharmaceuticals's Debt-to-Equity for the quarter that ended in Jun. 2020 is

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Alexion Pharmaceuticals Total Stockholders Equity Related Terms


Alexion Pharmaceuticals Total Stockholders Equity Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)